Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XRN
XRN logo

XRN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chiron Real Estate Inc (XRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
36.100
1 Day change
-0.58%
52 Week Range
37.810
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Chiron Real Estate Inc (XRN) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive analyst sentiment and a slight pre-market price increase, the company's financial performance shows significant losses, and there are no strong technical or proprietary trading signals to support immediate action. Holding off for better financial performance or clearer signals is advisable.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. The RSI is in the neutral zone at 76.777, suggesting no overbought or oversold conditions. Moving averages are converging, showing no clear trend. The stock is trading near resistance levels (R1: 35.784, R2: 36.674), which may limit further upside in the short term.

Options Data

Neutral
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The put-call ratios suggest a slightly bearish sentiment in the options market. Implied volatility is low (IV Percentile: 5.41, IV Rank: 15.73), indicating limited expectations of significant price movement.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • Analyst Gaurav Mehta raised the price target to $42, citing opportunities in active adult and senior housing with better returns. The MACD indicates bullish momentum.

Neutral/Negative Catalysts

  • The company's financial performance is weak, with a significant drop in net income (-639.88% YoY) and EPS (-650.00% YoY). No recent news or significant trading trends from insiders or hedge funds. Options data shows bearish sentiment, and the stock is near resistance levels, limiting short-term upside.

Financial Performance

In Q4 2025, revenue increased by 9.20% YoY to $38.39M. However, net income dropped significantly to -$7.42M (-639.88% YoY), and EPS fell to -0.55 (-650.00% YoY). Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Alliance Global analyst Gaurav Mehta maintains a Buy rating and increased the price target from $40 to $42, citing opportunities in senior housing with better returns compared to medical offices.

Wall Street analysts forecast XRN stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast XRN stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 36.100
sliders
Low
0
Averages
0
High
0
0
Current: 36.100
sliders
Low
0
Averages
0
High
0
Alliance Global
Gaurav Mehta
Buy
maintain
$40 -> $42
AI Analysis
2026-03-02
Reason
Alliance Global
Gaurav Mehta
Price Target
$40 -> $42
AI Analysis
2026-03-02
maintain
Buy
Reason
Alliance Global analyst Gaurav Mehta raised the firm's price target on Chiron Real Estate to $42 from $40 and keeps a Buy rating on the shares. The firm cites the company announcing that it will also invest in new active adult and operating senior housing, where Chiron is seeing opportunity in housing driven by less supply and attractive demographics, with better return profile as compared to medical offices, the analyst tells investors in a research note.

People Also Watch